Insulin – Page 2

Sanofi Invests €1.3 Billion in New Insulin Manufacturing Plant in Frankfurt

9 months ago talkbio0Tagged BioCampus, Diabetes, digital solutions, European (ethnic group), Frankfurt, Insulin, Manufacture, sanofi, supply chain

Sanofi, insulin manufacturing, Frankfurt, €1.3 billion, BioCampus, digital solutions, diabetes patients, European supply chain

FDA Rejects Novo Nordisk’s Once-Weekly Insulin Icodec for Diabetes Treatment

10 months ago talkbio0Tagged Complete, Diabetes, Diabetes Mellitus, Non-Insulin-Dependent, Icodec, Insulin, Nordisk, Response process, United States Food and Drug Administration, Weekly

FDA, Novo Nordisk, Icodec, Weekly Insulin, Diabetes Treatment, Type 1 Diabetes, Type 2 Diabetes, Complete Response Letter

FTC to Sue Major PBMs Over Insulin and Drug Prices Amid Anticompetitive Concerns

10 months ago talkbio0Tagged anticompetitive, Benefit, health companies, Insulin, legal action, manager, PBMs, Pharmaceutical Services, Practice Experience, Prices, United States Federal Trade Commission

FTC, PBMs, Insulin Prices, Drug Prices, Anticompetitive Practices, Pharmacy Benefit Managers, Health Companies, Legal Action

Vertex Announces Positive Results for VX-880 in Type 1 Diabetes Treatment

10 months ago talkbio0Tagged Allogeneic Human Stem Cell-derived Pancreatic Islet Cells VX-880, Diabetes, Hypoglycemic Events, Independence, Insulin, Severe (severity modifier), Stem Cell Therapy

Vertex Pharmaceuticals, VX-880, Type 1 Diabetes, Stem Cell Therapy, Insulin Independence, Severe Hypoglycemic Events

Lilly’s Weekly Insulin Therapy Excels in Two Major Clinical Trials, Narrowing Gap with Novo Nordisk

11 months ago talkbio0Tagged Administration occupational activities, Clinical Trials, Diabetes, Drug Industry, Eli Lilly, Insulin, insulin therapy, Nordisk, Primary Endpoint, trials, Weekly

Lilly, Novo Nordisk, weekly insulin, primary endpoint, pivotal trials, diabetes management, insulin therapy, clinical trials, diabetes treatment, pharmaceutical industry.